Cargando…
A large, consistent plasma proteomics data set from prospectively collected breast cancer patient and healthy volunteer samples
BACKGROUND: Variability of plasma sample collection and of proteomics technology platforms has been detrimental to generation of large proteomic profile datasets from human biospecimens. METHODS: We carried out a clinical trial-like protocol to standardize collection of plasma from 204 healthy and 2...
Autores principales: | Riley, Catherine P, Zhang, Xiang, Nakshatri, Harikrishna, Schneider, Bryan, Regnier, Fred E, Adamec, Jiri, Buck, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120690/ https://www.ncbi.nlm.nih.gov/pubmed/21619653 http://dx.doi.org/10.1186/1479-5876-9-80 |
Ejemplares similares
-
Ethnicity-Dependent and -Independent Heterogeneity in Healthy Normal Breast Hierarchy Impacts Tumor Characterization
por: Nakshatri, Harikrishna, et al.
Publicado: (2015) -
Radiation resistance in breast cancer: are CD44(+)/CD24(-)/proteosome(low)/PKH26(+ )cells to blame?
por: Nakshatri, Harikrishna
Publicado: (2010) -
Systemic Actions of Breast Cancer Facilitate Functional Limitations
por: Wang, Ruizhong, et al.
Publicado: (2020) -
PROGmiR: a tool for identifying prognostic miRNA biomarkers in multiple cancers using publicly available data
por: Goswami, Chirayu Pankaj, et al.
Publicado: (2012) -
PROGgene: gene expression based survival analysis web application for multiple cancers
por: Goswami, Chirayu Pankaj, et al.
Publicado: (2013)